Science Says Marijuana Is Not a Cure for Mental Health Problems
Recent research that examined over 50 clinical trials on marijuana for mental health found no real benefits. The studies covered conditions such as anxiety, depression, PTSD, and opioid addiction, but none showed that cannabis helped patients in any measurable way.
- Cochrane (January): THC for chronic pain showed no clear pain‑relief effect.
- JAMA (November): Led by UCLA, UCSF, and NYU researchers, cannabis does not work for most conditions it is marketed to treat, including acute pain and insomnia.
These findings starkly contrast with the growing number of states that allow doctors to prescribe medical marijuana—programs largely built on political campaigns rather than solid science.
Rising Risks
| Study | Population | Key Findings |
|---|---|---|
| JAMA Health Forum (Feb.) | Past‑year cannabis users | 2× more likely to develop psychosis or bipolar disorder; 34 % higher depression risk |
| Canadian Study (Feb.) | Cannabis‑use disorder patients | Over 12× higher likelihood of schizophrenia |
| Danish Study (2023) | ~7 million people | Cannabis‑use disorder linked to ~30 % of young men’s schizophrenia cases |
| Columbia University | Teens with marijuana use (no addiction) | 2–4× higher odds of mental health problems |
| Lancet (2019) | Daily users | 5× increase in psychosis risk |
| Lancet (1987) | Swedish data, heavy users | 6× higher risk of schizophrenia |
The evidence consistently points to harm rather than help.
Implications
Because the science is clear, states that now offer medical marijuana should reconsider their policies. Without reliable benefits and with documented risks, patients suffering from PTSD, chronic pain, or depression may be chasing a false promise that could worsen their health.
